Resultados de la búsqueda 141-150 of 10802 for monoclonal antibody

1. Oncología (médica) - Ensayos clínicos

   Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells ...